» Articles » PMID: 39963704

Association of Daily Body Temperature, White Blood Cell Count, and C-reactive Protein With Mortality and Persistent Bacteremia in Patients With Bacteremia: A Post Hoc Analysis of the CAMERA2 Randomized Clinical Trial

Overview
Date 2025 Feb 18
PMID 39963704
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Classification of patients with bacteremia as complicated versus uncomplicated is based on a combination of clinical and microbiologic variables. Whether daily body temperature and common laboratory tests such as C-reactive protein (CRP) and white blood cell (WBC) can improve risk stratification algorithms is unclear.

Methods: We conducted a post hoc secondary analysis of the CAMERA2 trial, which enrolled hospitalized adult patients with methicillin-resistant bacteremia and prospectively collected daily body temperature and peripheral blood WBC and CRP. We evaluated the prognostic relevance of each parameter by calculating crude and adjusted odds ratios for 90-day all-cause mortality comparing patients with the abnormal parameter of interest versus those with normal parameters on each day of illness.

Results: A total of 345 patients were included in this analysis, of whom 63 (18.3%) died within 90 days. Fever (body temperature ≥38.0 °C) was associated with increased odds of 90-day mortality from day 4 and onwards. Fever later in the illness course was associated with higher adjusted odds of mortality (8.78; 95% confidence interval, 2.78-27.7 on day 7 vs adjusted odds ratio 3.70; 95% CI, 1.58-8.67 on day 4). In contrast, CRP and abnormal WBC count did not demonstrate a consistent or temporal association with mortality.

Conclusions: Persistent fever after 72 hours is associated with increased mortality in patients with methicillin-resistant bacteremia, supporting recommendations that this should be kept as a criterion for classifying patients as either "high-risk" or "complicated." Within this dataset, there was limited additional predictive value in WBC or CRP.

References
1.
Molkanen T, Ruotsalainen E, Rintala E, Jarvinen A . Predictive Value of C-Reactive Protein (CRP) in Identifying Fatal Outcome and Deep Infections in Staphylococcus aureus Bacteremia. PLoS One. 2016; 11(5):e0155644. PMC: 4868312. DOI: 10.1371/journal.pone.0155644. View

2.
Tong S, Davis J, Eichenberger E, Holland T, Fowler Jr V . Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev. 2015; 28(3):603-61. PMC: 4451395. DOI: 10.1128/CMR.00134-14. View

3.
Ingram P, Cheng A, Murray R, Blyth C, Walls T, Fisher D . What do infectious diseases physicians do? A 2-week snapshot of inpatient consultative activities across Australia, New Zealand and Singapore. Clin Microbiol Infect. 2014; 20(10):O737-44. DOI: 10.1111/1469-0691.12581. View

4.
Kouijzer I, Fowler Jr V, Ten Oever J . Redefining Staphylococcus aureus bacteremia: A structured approach guiding diagnostic and therapeutic management. J Infect. 2022; 86(1):9-13. PMC: 11105116. DOI: 10.1016/j.jinf.2022.10.042. View

5.
Rowe T, McKoy J . Sepsis in Older Adults. Infect Dis Clin North Am. 2017; 31(4):731-742. DOI: 10.1016/j.idc.2017.07.010. View